FIELD: veterinary medicine.
SUBSTANCE: vaccine composition for immunization and/or protection of a mammal – a dog, a cat, or a horse – from a disease mediated by IL-31 is proposed, where the specified composition contains a combination of a polypeptide carrier and at least one mimotope of peptide IL-31, and an adjuvant. Mimotope of peptide IL-31 has a length from about 5 to about 40 amino acids, and it is selected from a group consisting of mimotope of dog IL-31, mimotope of cat IL-31, mimotope of horse IL-31, and mimotope of human IL-31. A method for protection of a mammal from a disease mediated by IL-31 is presented. The method includes administration to a mammal of the presented vaccine composition.
EFFECT: invention allows for obtaining a vaccine for reduction in skin itch and skin damage in dogs, cats, horses with atopic dermatitis.
20 cl, 39 dwg, 2 ex
Title | Year | Author | Number |
---|---|---|---|
MONOCLONAL ANTIBODIES TO INTERLEUKIN-31 FOR VETERINARY USE | 2019 |
|
RU2795411C2 |
ANTI-IL31 ANTIBODIES FOR VETERINARY USE | 2018 |
|
RU2795485C2 |
IL4/IL13 RECEPTOR MOLECULE FOR VETERINARY USE | 2018 |
|
RU2795591C2 |
IMMUNOCYTOKINES AND THEIR USE | 2021 |
|
RU2818371C1 |
EMBODIMENTS OF IGG-Fc FOR USE IN VETERINARY SCIENCE | 2018 |
|
RU2814952C2 |
ANTIBODY FOR SPECIFIC BINDING WITH INTERLEUKIN 4 RECEPTOR | 2017 |
|
RU2774446C2 |
ANTIBODY BINDING HUMAN IL-4R, ANTIGEN-BINDING FRAGMENT THEREOF, AND MEDICAL APPLICATION THEREOF | 2019 |
|
RU2779649C1 |
ANTIBODIES CONTAINING POLYPEPTIDE INTEGRATED INTO FRAME REGION 3 | 2019 |
|
RU2796254C2 |
ANTI-IL-5 ANTIBODIES | 2017 |
|
RU2758008C2 |
CD131-BINDING PROTEINS AND THEIR APPLICATIONS | 2016 |
|
RU2773927C2 |
Authors
Dates
2022-12-21—Published
2019-03-18—Filed